CIK 0001501989
- Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273521219
- Phone
- +1 650-515-3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-10-18 | THIRD ROCK VENTURES LP 10% owner | Other disposition | −1,000,000 | 3,320,348 | ||
| 2017-07-13 | THIRD ROCK VENTURES LP 10% owner | Other disposition | −850,000 | 4,320,348 | ||
| 2017-03-27 | THIRD ROCK VENTURES LP 10% owner | Sale | −650,000 | $18.00 | $11.7M | 5,170,348 |
| 2017-03-23 | THIRD ROCK VENTURES LP 10% owner | Sale | −1,000,000 | $17.00 | $17.0M | 5,820,348 |
| 2017-03-15 | THIRD ROCK VENTURES LP 10% owner | Other disposition | −850,000 | 6,820,348 | ||
| 2016-11-07 | THIRD ROCK VENTURES LP 10% owner | Other disposition | −1,000,000 | 7,670,348 | ||
| 2015-10-14 | THIRD ROCK VENTURES LP 10% owner | Conversion | +8,670,351 | 8,670,351 | ||
| 2015-10-14 | THIRD ROCK VENTURES LP 10% owner | Conversion · Series B-1 Preferred Stock | −8,105,314 | 0 | ||
| 2015-10-14 | THIRD ROCK VENTURES LP 10% owner | Conversion · Series C Preferred Stock | −565,037 | 0 |
Page 1 of 1 · 9 trades